Retatrutide
Description:
Retatrutide is a next-generation multi-receptor agonist designed to activate GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously. This triple-action mechanism is intended to support advanced metabolic regulation by influencing appetite control, energy expenditure, glucose metabolism, and fat utilization. Its broader receptor activity differentiates it from dual or single incretin-based compounds.
Compliance Notice:
For research use only. Not intended for human or veterinary use, medical treatment, or diagnostic applications. Users must comply with all applicable laws and regul
Research Applications:
Retatrutide is widely studied in metabolic and obesity-related research. It is used in investigations focusing on body weight regulation, insulin sensitivity, glucose homeostasis, and energy balance. Its triple agonist profile makes it particularly relevant for research into obesity, type 2 diabetes, and complex metabolic disorders.
Storage and Handling:
- Store at 2–8°C for short-term use
- For extended storage, keep at -20°C
- Protect from light and avoid repeated freeze-thaw cycles
- Keep container tightly sealed when not in use
- Handle using appropriate laboratory safety and aseptic techniques
Product Specifications:
Purity: ≥99% (HPLC Certified)
Appearance: Lyophilized White Powder
Solubility: Soluble In Suitable Laboratory Agents
Compliance Notice:
Retatrutide is intended for research purposes only. It is not designed for human or veterinary use and has not been evaluated by the FDA for commercial distribution in this form. Improper use is strictly prohibited and may violate federal, state, or local regulations. By purchasing this product, the buyer agrees that it will be used strictly for in vitro laboratory research. Not for human consumption.
| Size |
5mg ,10mg ,15mg ,20mg ,30mg ,40mg ,50mg ,60mg ,80mg ,100 mg |
|---|
RELATED PRODUCTS
Reviews
There are no reviews yet.